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Voltage-dependent K channels (VDPC) are expressed
in most mammalian cells and involved in the proliferation
and activation of lymphocytes. However, the role of VDPC
in macrophage responses is not well established. This
study was undertaken to characterize VDPC in macro-
phages and determine their physiological role during pro-
liferation and activation. Macrophages proliferate until
an endotoxic shock halts cell growth and they become
activated. By inducing a schedule that is similar to the
physiological pattern, we have identified the VDPC in
non-transformed bone marrow-derived macrophages and
studied their regulation. Patch clamp studies demon-
strated that cells expressed outward delayed and in-
wardly rectifying K currents. Pharmacological data,
mRNA, and protein analysis suggest that these currents
were mainly mediated by Kv1.3 and Kir2.1 channels.
Macrophage colony-stimulating factor-dependent prolif-
eration induced both channels. Lipopolysaccharide
(LPS)-induced activation differentially regulated VDPC
expression. While Kv1.3 was further induced, Kir2.1 was
down-regulated. TNF- mimicked LPS effects, and stud-
ies with TNF- receptor I/II double knockout mice dem-
onstrated that LPS regulation mediates such expression
by TNF--dependent and -independent mechanisms. This
modulation was dependent on mRNA and protein synthe-
sis. In addition, bone marrow-derived macrophages ex-
pressed Kv1.5 mRNA with no apparent regulation. VDPC
activities seem to play a critical role during proliferation
and activation because not only cell growth, but also in-
ducible nitric-oxide synthase expression were inhibited
by blocking their activities. Taken together, our results
demonstrate that the differential regulation of VDPC is
crucial in intracellular signals determining the specific
macrophage response.
Immune system responses to an antigen involve a complex
network of several cell types. Among them, the mononuclear
phagocyte family comprises numerous cell types, including tis-
sue macrophages, Kupffer cells, dermal Langerhans cells, os-
teoclasts, microglia, and perhaps some of the interdigitating
and follicular dendritic cells from lymphoid organs (1). Macro-
phages perform critical functions in the immune system, acting
as regulators of homeostasis and as effector cells in infection,
wounding, and tumor growth. In response to different growth
factors and cytokines, macrophages can proliferate, become
activated or differentiate. As monocytes differentiate into ma-
ture, non-proliferating macrophages they can produce a large
variety of responses, including chemotaxis, phagocytosis, and
secretion of numerous cytokines and other substances. To elicit
the appropriate physiological response plasma membrane pro-
tein expression changes dramatically from proliferation to
activation (2).
Voltage-dependent potassium channels (VDPC)1 are a group
of plasma membrane ion channels with a key role in controlling
repolarization and resting membrane potential in electrically
excitable cells. K channels are also involved in the mainte-
nance of vascular smooth muscle tone, glucose-stimulated in-
sulin release by -pancreatic cells, cell volume regulation, and
cell growth (3). Leukocytes express a number of voltage-gated
and/or second messenger-modulated ion channels, and the elec-
trophysiological properties of many of these channels are
known (4–17). Despite considerable progress, important ques-
tions remain unsolved, the relationship of these proteins to cell
function being one of the most relevant (18–20). VDPC are
associated with macrophage functions such as migration, pro-
liferation, activation, and cytokine production (see Refs. 18 and
19 for reviews). Although microglia appears to express most
neuronal channels, circulating macrophages have a number of
VDPC yet to be defined (19). These proteins have been studied
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in various cellular models, and outward delayed and inwardly
rectifying K currents have been identified. Furthermore, the
presence of the shaker-like Kv1.3 and Kir2.1 channels has been
detected in some studies. However, the use of either activated
or transformed macrophage cell lines has led to controversial
results (4–20). Thus, while a high-conductance Ca2-depend-
ent K channel has been clearly identified as an early step in
transmembrane signal transduction in macrophages (21), the
physiological role of VDPC in either proliferation or activation
is not known. Primary culture of bone marrow-derived macro-
phages (BMDM) is a unique non-transformed model in which
proliferation and activation can be studied separately, mimick-
FIG. 1. Macrophages express outward delayed and inwardly rectifying K currents. A, representative traces of K currents. Cells were
held at 60 mV and pulse potentials were applied as indicated. B, cumulative inactivation of outward currents. Currents were elicited by a train
of 8 depolarizing voltage steps (200 ms duration) to 50 mV once every 400 ms. The current amplitude became progressively smaller from the first
trace to the last. C, dose-dependent inhibition curves of the outward current by MgTx () and ShK-Dap22 (E). Currents were evoked at 50 mV
from a holding potential of 60 mV during a pulse potential of 200 ms. The percent of inhibition was calculated by comparing the current at a given
concentration of toxin versus that obtained in its absence. D, dose-dependent inhibition of the inwardly rectifying current by Ba2. E, dose-de-
pendent inhibition of the inwardly rectifying current by Cs.
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ing physiological processes that occur in the body (22). Macro-
phages are generated in the bone marrow and, through the
bloodstream, reach all tissues, stop proliferation, and become
activated (2). Macrophage colony-stimulating factor (M-CSF) is
the specific growth factor for this cell type (23). On the other
hand, lipopolysaccharide (LPS) is a major component of the
outer Gram-negative bacteria membrane, which interacts with
monocytes/macrophages and induces a variety of intracellular
signaling cascades, finally leading to the release of endogenous
mediators such as TNF-, IL-1, and IL-6 (24). Furthermore,
LPS triggers cellular activation and apoptosis by an early TNF-
-dependent mechanism (25).
Several VDPC candidates could be present in macrophages
and our first interest was to identify these channels in a pri-
mary culture of BMDM. Macrophages mainly expressed the
outward delayed Kv1.3 and the inwardly rectifying Kir2.1 po-
tassium channels. Because VDPC could be involved not only in
proliferation but also in activation, our second goal was to
determine their specific role by inducing a schedule that is
similar to the physiological pattern in BMDM. M-CSF-depend-
ent proliferation led to an up-regulation of VDPC generating an
increase in potassium current densities without changes in
current kinetics. When cells were further incubated with LPS
the electrophysiological properties changed dramatically.
FIG. 2. Voltage-dependent K channel expression in macrophages. A, mRNA expression of Kv1.3 and Kir2.1 in the mouse brain and
macrophages but not in the liver. 1 g of total RNA was used in RT-PCR reactions as described under “Experimental Procedures.” B, Kv1.3 and
Kir2.1 protein expression in the mouse brain and BMDM. Western blot analysis were performed in the presence and the absence of the control
antigen peptide. C, VDPC expression in BMDM. RT-PCR was set as described under “Experimental Procedures” with oligonucleotides from Kv1.1
(accession number NM_010595; base pairs 1102–1807), Kv1.2 (accession number NM_008417, base pairs 841–1691), Kv1.5 (accession number
AF302768, base pairs 3003–3337), Kv1.6 (accession number NM_013568, base pairs 233–1822), and Kv3.1 (accession number Y07521, base pairs
727–1231). Lanes 1, 3, 5, 7, 9, and 10, PCR reactions from BMDM. Lanes 2, 4, 6, 8, 11, PCR from mouse brain. Lane 9 of Kv1.5 is a negative control
in the absence of the RT reaction. PCR products were run in a 1% agarose gel. D and E, immunocytochemical electron microscopic detection of Kv1.3
and Kir2.1 proteins, respectively. Arrows show specific channel protein localization. Bars indicate 0.25-m scale.
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FIG. 3. M-CSF-dependent proliferation induces VDPC in macrophages. A, cells were incubated for 24 h in the presence (M-CSF) or
absence (M-CSF) of the growth factor. Representative outward and inward traces were elicited by a hyperpolarizing step from 60 to 150 mV
and a depolarizing step from 60 to 50 mV for 200 ms, respectively. B, current density versus voltage relationship of K currents. Macrophages
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Thus, Kv1.3 was further increased, whereas Kir2.1 was down-
regulated. We also show that TNF- partially mimicked the
response to LPS, suggesting that there are TNF--dependent
and -independent mechanisms mediating LPS-induced VDPC
modulation in macrophages. Our results have physiological
relevance and indicate that VDPC expression is important as
an early regulatory step, and fine-tuning modulation of their
expression is crucial to the specific membrane signaling that
triggers the appropriate immune response.
EXPERIMENTAL PROCEDURES
Animals and Cell Culture—BMDM from 6- to 10-week-old BALB/c or
C57/BL6 mice (Charles River Laboratories) were used. Cells were iso-
lated and cultured as described elsewhere (22). Briefly, animals were
killed by cervical dislocation, and both femurs were dissected removing
adherent tissue. The ends of bones were cut off and the marrow tissue
was flushed by irrigation with medium. The marrow plugs were passed
through a 25-gauge needle for dispersion. The cells were cultured in
plastic dishes (150 mm) in Dulbecco’s modified Eagle’s medium contain-
ing 20% fetal bovine serum and 30% supernatant of L-929 fibroblast
(L-cell) conditioned media as a source of M-CSF. Macrophages were
obtained as a homogeneous population of adherent cells after 7 days of
culture and maintained at 37 °C in a humidified 5% CO2 atmosphere.
For experiments, they were cultured with the same tissue culture
differentiation medium (Dulbecco’s modified Eagle’s medium, 20% fetal
bovine serum, 30% L-cell medium) or arrested at G0 by M-CSF depri-
vation in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum for at least 18 h. G0-arrested cells were further
incubated in the absence or presence of recombinant murine M-CSF
(1200 units/ml), with or without LPS (100 ng/ml) or TNF- (100 ng/ml),
for the indicated times. In some experiments, cells were exposed to
rMargatoxin (MgTx), BaCl2, cycloheximide, and actinomycin D as pre-
viously described (26–30).
The TNF- receptor I/II double knockout mice (C57/BL6) used in this
study were generated and characterized as previously reported (25, 31).
All animal handling was approved by the ethics committee of the
University of Barcelona in accordance with EU regulations.
DNA Synthesis—DNA synthesis was measured as the incorporation
of [3H]thymidine (Amersham Biosciences) to DNA, as described else-
where (22). Briefly, macrophages (5  104) were seeded in 24-well plates
in 1 ml of medium without M-CSF for at least 18 h. Cells were then
cultured for a further 24 h in the absence or presence of M-CSF with/
without LPS, TNF-, MgTx, or BaCl2 (1 mM). Finally, the medium was
removed and replaced with 0.5 ml of the same medium containing 1
Ci/ml [3H]thymidine. After three additional hours of incubation, cells
were fixed in 70% methanol, washed three times in ice-cold 10% tri-
chloroacetic acid, and solubilized in 1% SDS and 0.3% NaOH. The whole
content of the well was used for counting radioactivity.
RNA Isolation and RT-PCR Analysis—Total RNA from mouse
macrophages, brain, and liver was isolated using the Tripure reagent
(Roche Diagnostics), following the manufacturer’s instructions. Sam-
ples were further treated with the DNA-free kit from Ambion Inc. to
remove DNA.
Ready-to-Go RT-PCR beads (Amersham Biosciences) were used in a
one-step RT-PCR as described elsewhere (22, 32–34). Total RNA and
selected primers at 1 M were added to the beads. The RT reaction was
initiated by incubating the mixture at 42 °C for 30 min. Once the
first-strand cDNA had been synthesized, the conditions were set for
further PCR: 92 °C for 30 s, either 55 °C (Kv1.3 and 18S) or 60 °C
(Kir2.1) for 1 min and 72 °C for 2 min. These settings were applied for
40 cycles. Every 10 cycles, 10 l of the total reaction was collected in a
separate tube for further electrophoresis and analysis. A range of dilu-
tions of RNA from each independent sample was performed to obtain an
exponential phase of amplicon production (not shown) as described
previously (32). The same independent RNA aliquot was used to ana-
lyze the VDPC mRNA expression and the respective amount of 18 S
rRNA. Primer sequences and accession numbers were: Kv1.3 (accession
number M30441), forward, 5-CTCATCTCCATTGTCATCTTCTGA-3
(base pairs 741–765) and reverse, 5-TTGAATTGGAAACAATCAC-3
(base pairs 1459–1440); Kir2.1 (accession number AF021136), forward,
5-TGGCTGTGTGTTTTGGTTGATAGC-3 (base pairs 297–320) and re-
verse, 5-CTTTGCCATCTTCGCCATGACTGC-3 (base pairs 555–532);
and 18 S (accession number X00686), forward, 5-CGCAGAATTCCCA-
CTCCCGACCC-3 (base pairs 482–498) and reverse, 5-CCCAAGCTC-
CAACTACGAGC-3 (base pairs 694–675). Kv1.5 and other Kv mRNA
expression was analyzed by PCR as previously described (33). In all
cases negative controls were performed in the absence of the RT
reaction.
Once the exponential phase of the amplicon production had been
determined the specificity of each product was confirmed in test RT-
PCR using the appropriate cDNA probe in a Southern blot analysis.
PCR-generated VDPC cDNA probes from mouse brain were subcloned
using the pSTBlue-1 acceptor vector kit (Novagen) and the sequences
were confirmed using the Big Dye Terminator Cycle sequencing kit and
an ABI 377 sequencer (Applied Biosystems). EcoRI-digested [-32P]CTP
random primer-labeled cDNAs were used as probes as previously de-
scribed (34). At least three different filters were made from independent
samples and representative blots are shown. Results were analyzed
with Phoretix software (Nonlinear Dynamics).
Protein Extracts and Western Blot—Cells were washed twice in cold
phosphate-buffered saline (PBS) and lysed on ice with lysis solution (1%
Nonidet P-40, 10% glycerol, 50 mmol/liter HEPES, pH 7.5, 150 mmol/
liter NaCl) supplemented with 1 g/ml aprotinin, 1 g/ml leupeptin, 86
g/ml iodoacetamide, and 1 mM phenylmethylsulfonyl fluoride as pro-
tease inhibitors. Sample protein concentration was determined by Bio-
Rad protein assay. The proteins from cell lysates (100 g) were boiled at
95 °C in Laemmli SDS-loading buffer and separated on 10% SDS-
PAGE. They were transferred to nitrocellulose membranes (Immo-
bilon-P, Millipore), and blocked in 5% dry milk-supplemented 0.2%
Tween 20 PBS prior to immunoreaction. To monitor Kv1.3 and Kir2.1
expression, rabbit polyclonal antibodies (Alomone Labs) were used. To
study the expression of inducible nitric-oxide synthase (iNOS), a rabbit
antibody against mouse iNOS (Santa Cruz Biotechnology) was used.
The rabbit polyclonal anti-Kv1.5 antibody was a kind gift from Dr.
M. M. Tamkun (Colorado State University). As a loading and transfer
control, a monoclonal anti--actin antibody (Sigma) was used.
Electron Microscopy—Cell monolayers on Petri dishes were scraped
and collected into PBS buffer. BMDM were cryofixed by high-pressure
freezing using an EMPact (Leica). Freeze substitution was performed in
an “Automatic Freeze Substitution system” (AFS) from Leica, using
acetone containing 0.5% of uranyl acetate, for 3 days at 90 °C. On the
fourth day, the temperature was slowly increased, 5 °C/h, to 50 °C. At
this temperature samples were rinsed in acetone and then infiltrated
and embedded in Lowicryl HM20. Ultrathin sections were picked up on
Formvar-coated copper-palladium grids. For immunogold localization,
samples were blocked with 10% fetal calf serum in PBS for 20 min and
incubated at room temperature for 1 h with polyclonal anti-Kv1.3 or
anti-Kir2.1 (1:200). Washes were performed with PBS prior to adding
goat anti-rabbit conjugated to 10 nm colloidal gold (BioCell Research
Laboratory) for 1 h at room temperature. Finally, samples were washed
and contrasted with 2% uranyl acetate for 30 min and observed in a
Hitachi 600AB electron microscope.
Electrophysiological Recordings—Whole cell currents were meas-
ured using the patch clamp technique. An EPC-9 (HEKA) with the
appropriate software was used for data recording and analysis. Cur-
rents were filtered at 2.9 kHz. Series resistance compensation was
always above 70%. Patch electrodes of 2–4 Mohms were fabricated in a
P-97 puller (Sutter Instruments Co.) from borosilicate glass (outer
diameter 1.2 mm and inner diameter 0.94 mm; Clark Electromedical
Instruments Co.). Electrodes were filled with the following solution (in
mM): 120 KCl, 1 CaCl2, 2 MgCl2, 10 HEPES, 11 EGTA, 20 D-glucose,
adjusted to pH 7.3 with KOH. The extracellular solution contained (in
mM): 120 NaCl, 5.4 KCl, 2 CaCl2, 1 MgCl2, 10 HEPES, 25 D-glucose,
adjusted to pH 7.4 with NaOH. After establishing the whole cell con-
figuration of the patch clamp technique macrophages were clamped to
were held at 60 mV and pulse potentials as described in the legend to Fig. 1 were applied. Conductance was plotted against test potentials. C,
steady-state activation curves of the outward current. Conductance above holding potentials were normalized to the peak current density at 50
mV. D, steady-state activation curves of the inwardly rectifying current. Conductance below holding potentials were normalized to the current
density at 150 mV. Symbols for B–D panels are: E, M-CSF; , M-CSF. E, Kv1.3 and Kir2.1 mRNA expression. Samples were collected after
the addition of M-CSF and RT-PCR analysis was performed as described under “Experimental Procedures” at the indicated times. Values are the
mean  S.E. (n  4). Significant differences were found with Kv1.3 and Kir2.1 (p  0.001, ANOVA). F, Kv1.3 and Kir2.1 protein expression in
BMDM cultured during 24 h in the absence () or presence () of M-CSF.
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a holding potential of 60 mV. To evoke voltage-gated currents all cells
were stimulated with 200-ms square pulses ranging from 150 to 50
mV in 10-mV steps. All recordings were routinely subtracted for leak
currents.
The pharmacological characterization of the inward rectifier K cur-
rent was performed by adding to the external solution BaCl2 and CsCl
at various concentrations (28). To block the outward current, MgTx and
ShK-Dap22 were added to the external solution (26, 27). Before exper-
iments, toxins were reconstituted to 10 M in Tris buffer (0.1% bovine
serum albumin, 100 mM NaCl, 10 mM Tris, pH 7.5). All recordings were
done at room temperature (20–23 °C).
Reagents—Recombinant murine TNF- was obtained from Prepo-
Tech EC. Recombinant murine M-CSF was from R&D Systems. Cyclo-
heximide, actinomycin D, LPS, CsCl, and BaCl2 were purchased from
Sigma, and MgTx from Alomone Labs. ShK-Dap22 was from Bachem
Biosciences Inc. Other reagents were of analytical grade.
Analysis and Statistics—According to the solutions used, the calcu-
lated equilibrium potential for potassium was 79 mV (EK) using the
Nernst equation. The normalized G/Gmax versus voltage curve was
fitted using Boltzmann’s equation: G/Gmax  1/(1  exp
((V[1,2]V)/k)),
where V1⁄2 is the voltage at which the current is half-activated and k is
the slope factor of the activation curve.
Values are expressed as the mean  S.E. The significance of differ-
ences was established by either Student’s t test or one way ANOVA
(Graph Pad, PRISM 3.0) for either two-group or two-factor comparison,
respectively. A value of p  0.05 was considered significant.
RESULTS
Macrophages Express Outward and Inward K Currents:
Pharmacology and Molecular Characterization of Kv1.3 and
Kir2.1—Cells (n  80) plated in the presence in L-cell-condi-
tioned medium expressed outward delayed and inward rectifier
potassium currents (Fig. 1A). Following a train of 200-ms de-
polarizing pulses to 50 mV at 400-ms intervals, the outward
current showed a characteristic cumulative inactivation phe-
nomenon (Fig. 1B). Fig. 1C shows the effect of MgTx and
ShK-Dap22 on the outward conductance. The IC50 for inhibition
were 5 and 3 pM for MgTx and ShK-Dap22, respectively.
These results indicated that Kv1.3 would be the main channel
responsible for the outward potassium current. On the other
hand, the high sensitivity to Ba2 (Fig. 1D) and Cs (Fig. 1E),
together with the closed state above 0 mV of the inward cur-
rent, indicated that the channel was Kir2.1. To identify K
channels at the molecular level, we performed RT-PCR analy-
ses. Mouse brain and liver RNAs were used as positive and
negative controls, respectively. Fig. 2A shows that macro-
phages expressed Kv1.3 and Kir2.1 mRNA to a similar extent
to that observed in the brain. In addition, specific Kv1.3 and
Kir2.1 signals were obtained by Western blot analysis in brain
and BMDM protein samples (Fig. 2B). The presence of other
VDPC (Kv1.1, Kv1.2, Kv1.6, and Kv3.1) analyzed by RT-PCR
was negative (Fig. 2C). However, BMDM expressed Kv1.5
mRNA but the protein expression was below detection levels
analyzed by Western blot (Fig. 2C and data not shown).
The expression of Kv1.3 and Kir2.1 proteins in macrophages
was further confirmed by electron microscopic immunocyto-
chemical detection studies with specific antibodies (Fig. 2, D
and E, respectively). Taken together, these data indicate that
BMDM have outward delayed and inward rectifier potassium
currents that are mainly conducted by Kv1.3 and Kir2.1 K
channels.
M-CSF-dependent Proliferation Induces Kv1.3 and Kir2.1—
M-CSF is the specific growth factor for this cell type. Macro-
phages incubated for about 18 h in the absence of this factor
stopped cell growth (	98%) and became quiescent (22). The
addition of M-CSF triggered macrophage proliferation (not
shown) and outward and inward K currents were induced
after 24 h of incubation (Fig. 3A). The current density (pA/pF)/
voltage relationships depicted in Fig. 3B showed that M-CSF
increased currents up to 3-fold. The number and density of the
channels were increased during M-CSF-dependent prolifera-
tion. Whereas at 50 mV resting cells expressed 30 channels/
cell with a density of 0.017 channel/m2, proliferating cells
showed 90 channels/cell and 0.05 channel/m2. A large
increase was also observed in the inward current at 150 mV.
Thus, M-CSF-treated macrophages increased from 80 to
275 channels/cell and from 0.044 to 0.15 channel/m2 for
the number and channel density, respectively. Normalized con-
ductance demonstrated that both groups showed similar pat-
terns. Thus, outward currents (Fig. 3C) indicated that channels
were open at depolarizing potentials with a V1⁄2 of 10.53  2.8
and 11.33  2.1 mV and k of 20  3 and 21  3 for resting
(M-CSF) and proliferating (M-CSF) cells, respectively (n 
20). Moreover, the steady-state activation of inward currents
(Fig. 3D) was also similar, with V1⁄2 values of 105  2 and
109  2 mV and slopes k of 12.0  1 and 12.4  1 for
M-CSF and M-CSF cells, respectively (n  20).
Fig. 3E illustrates the time course of Kv1.3 and Kir2.1 gene
expression after the addition of M-CSF. The expression of both
VDPC increased by up to 3-fold. However, whereas Kv1.3
reached the highest levels after about 6 h, Kir2.1 expression
increased steadily throughout the study. Similar changes were
obtained in Kv1.3 and Kir2.1 protein abundance in BMDM
incubated during 24 h in the presence of M-CSF (Fig. 3F). No
differences were observed in the absence of M-CSF throughout
the study. Taken together, these data indicate that M-CSF-de-
pendent proliferation leads to long term increases in current
densities of outward and inward currents in accordance with
an induction in mRNA and protein expression.
LPS-induced Activation Regulates Differentially Kv1.3 and
Kir2.1—Proliferating macrophages reach body tissues and are
activated by physiological processes. The addition of LPS for
24 h in the presence of M-CSF inhibited proliferation (99.5 
0.5%, n  12). LPS also increased the outward current concom-
itantly to a reduction in the inward current (Fig. 4A). The
current density/voltage relationship depicted in Fig. 4B indi-
cates that at depolarizing potentials the current was increased
4-fold, whereas at hyperpolarizing potentials the inward cur-
rent was reduced about 5-fold. Thus, in the presence of LPS the
number of the outward delayed rectifier functional channels
and their density was 5 times larger that in its absence at 50
mV (90 and 420 channels/cell and 0.05 and 0.25 chan-
nel/m2, respectively). On the contrary, at 150 mV, the num-
ber and density of the inward channels decreased, being 40
and 275 channels/cell and 0.022 and 0.15 channel/m2 for
LPS-treated and untreated macrophages, respectively. In the
presence of 10 nM MgTx outward currents were totally inhib-
ited, with no effect on the inward conductance (Fig. 4C). Fig. 4D
shows the steady-state activation curves of the normalized
outward current above the holding potential. Whereas V1⁄2 val-
ues were similar for both groups (12.8  1.1 and 15.7  3.6
mV for LPS and LPS, respectively, n  10), k slope values
were significantly different (21.0  3 and 9.3  1.2 for LPS
and LPS, respectively, p  0.001, n  10). However, when the
steady-state activation curves of inward currents were ana-
lyzed (Fig. 4E), both groups showed similar characteristics.
Thus, V1⁄2 values were 108  2 and 105.8  1 mV and k
values were 12.6  1 and 11.9  1 for LPS and LPS,
respectively (n  10).
Fig. 5 shows Kv1.3 and Kir2.1 expression in the presence of
M-CSF with or without LPS at different times. The presence of
LPS induced the expression of Kv1.3 mRNA about 4-fold after
3 h (Fig. 5A). After 24 h, Kv1.3 mRNA still was 275% above
control. In contrast, Kir2.1 mRNA decreased steadily. Fig. 5B
shows that the mRNA regulation observed for Kv1.3 and
Kir2.1 was mirrored by similar changes in protein expression
levels.
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TNF- Regulates Kv1.3 and Kir2.1 Similarly to LPS, Evi-
dence for LPS Modulation by TNF--dependent and -inde-
pendent Mechanisms—TNF- produced by macrophages and
lymphocytes mediates a number of events induced by LPS,
including activation, apoptosis, and the nucleoside uptake (25,
35). To examine whether TNF- mediates LPS regulation of
FIG. 4. LPS-induced activation regulates K currents differentially in macrophages. BMDM were incubated with M-CSF for 24 h in the
presence (LPS) or absence (LPS) of the endotoxin. A, representative outward and inward traces were elicited as indicated. B, current density
versus voltage representation of K currents. Macrophages were held at 60 mV and pulse potentials were applied as indicated in the legend to
Fig. 1. C, current density/voltage relationship of the specific inhibition of outward K currents by 10 nM MgTx. Cells were treated with LPS and
currents were evoked in the presence (E) or absence () of MgTx. Pulse potentials were applied as indicated in the legend to Fig. 1. D, steady-state
activation curve of the outward current. Conductance above the holding potentials were normalized to the peak current density at 50 mV. E,
steady-state activation curves of the inwardly rectifying current. Conductance below the holding potentials were normalized to the peak current
density at 150 mV. Symbols for B–E panels: E, LPS; , LPS. Values are the mean  S.E. (n  10).
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VDPC, macrophages in the presence of M-CSF were incubated
for 24 h with (TNF-) or without (TNF-) TNF-, and K
currents were analyzed (Fig. 6). The cytokine increased the
outward current and decreased the inward (Fig. 6A). Current
density/voltage relationships (Fig. 6B) demonstrated that at
depolarizing potentials the outward current was 3-fold induced
while at hyperpolarizing potentials the inward was 6-fold
lower. In addition, at a potential of 50 mV, there was a
considerable increase in the number and density of outward
channels (90 and 240 channels/cell; 0.15 and 0.22 chan-
nel/m2 for TNF- untreated and treated cells, respectively), at
150 mV the number and density of the inward ones was lower
(275 and 40 channels/cell; 0.15 and 0.022 channel/m2).
The steady-state activation curves for outward and inward
currents are shown in Fig. 6, C and D, respectively. Outward
current V1⁄2 values were similar for both groups (13.1  2.7
and 17.0  2.0 mV for TNF- and TNF-, respectively,
n  9). However, k slope values were different (21.0  3 and
9.8  1 for TNF- and TNF-, respectively, p  0.001, n 
9). Inward currents were similar (Fig. 6D), with V1⁄2 values
107.6  2 and 107.9  2 mV, and k values 16.7  1.3 and
18.8  1.5 for TNF- and TNF-, respectively (n  9).
The expression of Kv1.3 and Kir2.1 mRNA and protein was
also analyzed (Fig. 7). Kv1.3 mRNA induction peaked (3-fold)
after 3 h of incubation (Fig. 7A) and remained high throughout
the study. Kir2.1 mRNA expression decreased for the first 6 h
and remained low (about 30% of basal) for a further 24 h.
Similarly to what was found with the mRNA, VDPC protein
abundance was differentially regulated (Fig. 7B). Thus,
whereas Kv1.3 showed a significant increase (180%) after
24 h, Kir2.1 protein expression decreased about 50%.
To further explore the role of TNF- in the LPS signaling, we
used BMDM from TNF- receptor I/II double knockout mice.
As expected, TNF- triggered Kv1.3 up-regulation and Kir2.1
down-regulation only in wild type (/) but not in TNF-
receptor I/II double knockout (/) cells (Fig. 8, C and D).
Interestingly, LPS induced Kv1.3 and down-regulated Kir2.1
in both groups (Fig. 8, A and B). Taken together, these results
indicate that although the autocrine production of TNF- reg-
ulates VDPC similarly to LPS, redundant pathways must be
involved.
Macrophage Proliferation and Activation Require VDPC Ex-
pression—Proliferation induced outward and inward K cur-
rents in macrophages. However, LPS and TNF- triggered an
induction of the outward current, whereas the inward current
decreased (Fig. 9A). Concomitantly, the mRNA and protein
expression of both VDPC were regulated differentially. Ion
channels are under extensive regulation, and changes among
different expression levels have been reported. However, in
long term studies, VDPC mRNA mostly governs protein and
activity (13, 34, 36). The regulation of K currents was depend-
ent on mRNA and protein de novo synthesis because it was
prevented by the presence of either actinomycin D or cyclohex-
imide (Fig. 9A). To examine whether other VDPC, besides
Kv1.3, were involved in the M-CSF-dependent proliferation
and LPS- or TNF--induced activation, currents were evoked in
the presence or absence of MgTx (Fig. 9B) and ShK-Dap22 (Fig.
9C). Similar results were obtained in all conditions, indicating
that Kv1.3 is the main channel responsible for the outward
currents. However, because Kv1.5 mRNA was detected in
BMDM by RT-PCR, we analyzed its expression in macrophages
cultured under distinct stimuli (Fig. 9D). Neither M-CSF-de-
pendent proliferation nor LPS- and TNF--induced activation
regulated Kv1.5 mRNA expression.
To further analyze the physiological role of VDPC during
macrophage proliferation, cells were incubated for 24 h in the
presence of M-CSF with or without MgTx and Ba2. The addition
of MgTx inhibited BMDM proliferation in a dose-dependent man-
FIG. 5. LPS-induced activation up-
regulates Kv1.3 and down-regulates
Kir2.1 VDPC. A, RT-PCR analysis of
Kv1.3 and Kir2.1 mRNA expression at
different times after LPS treatment. Re-
sults from RT-PCR on 0.25 g of total
RNA for 30 cycles for Kv1.3 and Kir2.1
and 0.1 g of RNA and 10 cycles for 18 S
are shown. These conditions were at the
exponential phase of the amplicon pro-
duction as described under “Experimental
Procedures.” , Kv1.3; E, Kir2.1; f, 18 S.
Significant differences were found with
Kv1.3 and Kir2.1 (p  0.001, ANOVA). B,
Kv1.3 and Kir2.1 Western blot analysis.
Cells were incubated for 24 h with
(LPS) or without (LPS) the endotoxin.
Open bars, Kv1.3; closed bars, Kir2.1;
hatched bars, -actin. **, p  0.01; ***,
p  0.001 versus LPS (Student’s t test).
Representative filters are shown. Values
are mean  S.E. of four independent
experiments.
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ner with a IC50 of 2.2 nM (Fig. 9E). Moreover, cell growth was also
lower in the presence of 1 mM Ba2 (52  6%, n  9) and the
addition of 10 nM MgTx further inhibited [3H]thymidine incorpo-
ration (69  4%, n  6, p  0.05 versus 1 mM Ba2 or 10 nM MgTx
alone). These results indicate that Kv1.3 and Kir2.1 could be
involved in the BMDM proliferation in an additive way.
The role of TNF- in the LPS-induced activation seems to be
partial, because not only the outward K current but also the
proliferation were modulated to a lesser extent by TNF-.
Thus, while LPS totally abolished cell growth (see above), the
inhibition of [3H]thymidine incorporation in the presence of
TNF- was 61  5%. In addition, the pharmacological blockage
of VDPC was additive, because proliferation was further de-
creased when either 10 nM MgTx or 1 mM Ba2 was added to
TNF- (91  10 and 80  4%, respectively, n  6, p  0.001
versus TNF- alone).
The potential role of VDPC during proliferation and activa-
tion was further supported by the effects of MgTx on iNOS
expression in BMDM (Fig. 9F). iNOS is dependent on K
channel activity in macrophage-like cell lines (37), and simi-
larly to IL-2 in T-cell (38), could be considered as a marker of
macrophage activation (25, 35). LPS and TNF--induced acti-
vation triggered an increase in iNOS expression and the pres-
ence of 10 nM MgTx inhibited iNOS induction (Fig. 9F).
DISCUSSION
Since the early 1980s several laboratories have been charac-
terizing ion channels in red blood cells and leukocytes. Several
FIG. 6. TNF- regulates K currents differentially in macrophages. BMDM were incubated with M-CSF for 24 h in the presence (TNF-)
or absence (TNF-) of the cytokine. A, representative outward and inward traces were elicited as indicated. B, current density/voltage
relationship of K currents. Cells were held at 60 mV and pulse potentials were applied as indicated in the legend to Fig. 1. C, steady-state
activation curves of the outward current. Conductance above holding potentials were normalized to the peak current at 50 mV. D, steady-state
activation curves of the inwardly rectifying current. Conductance below the holding potentials were normalized to the peak current at 150 mV.
E, TNF-; , TNF-. Values are the mean  S.E. (n  9).
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types of voltage-dependent sodium, chloride, proton, and potas-
sium currents have been identified in macrophages of diverse
origin. Among them, voltage-gated outward and inward K
currents have been the most studied. In leukocytes, whereas
outward K currents contribute to restoring membrane poten-
tial after depolarization, inward K currents have a key role
after hyperpolarization (see Refs. 18–20 and 37 for reviews).
Voltage-dependent K Channels in Bone Marrow-derived
Macrophages—The present study identifies for the first time
the VDPC expressed in non-transformed macrophages. BMDM
is a cell model that follows the physiological schedule within
the body (2, 22, 25). Mature cells may proliferate or become
activated after a specific stimulus. The use of dedifferentiated
cell lines (THP-1 or HL-60 among others) as well as thioglycol-
late-elicited peritoneal macrophages, blood monocytes, or mi-
croglia has yielded controversial results (4–20, 39–42). Those
data imply that K channels expressed in macrophages depend
on the source and the differentiated status of the cells. Fur-
thermore, the presence of K currents in BMDM had been
reported but the proteins responsible had not been identified
(42). Our results indicate that Kv1.3 is the main channel re-
sponsible for the outward current and Kir2.1 is responsible for
the inward.
The presence of other candidates was tested in our model.
Lymphocytes express several voltage-dependent K currents
(n, n, and l-type channels). While Kv1.3 is associated with the
n-type channel and Kv3.1 accounts for the l-type, the protein
responsible for the n-type is unknown (38). In addition, other
channels have been described in immune system cells. Thus,
KCNE1 (also named Isk) was cloned from T-cells (43), Kv1.1
was found in CD4CD8 thymocytes (44) and Kv1.5 was iden-
tified in non-proliferating hippocampal microglia (45). We did
not find Kv3.1 and Kv1.1 in macrophages by RT-PCR. Other
related Kv1 channels such as Kv1.2 and Kv1.6 were also absent
in our model. This result is consistent with the specific block-
age of the outward current by MgTx and ShK-Dap22, even
when cells proliferated or were activated. However, the expres-
sion of Kv1.5 indicates that heterotetrameric structures be-
tween Kv1.3 and Kv1.5 would be possible and should be
considered.
M-CSF-dependent Proliferation Versus LPS-induced Activa-
tion—VDPC are implicated in proliferation and activation.
Their role in G1/S cell cycle progression has been reviewed, and
their function in IL-2 secretion by T-lymphocytes has been
demonstrated (38). However, different cell models produce con-
troversial results. Whereas in some cell lines the differentia-
tion is a prerequisite for VDPC expression, the macrophage
phenotype often determines the loss of specific ion channel
properties (18). Many studies have used B- and T-cells. How-
ever, lymphocyte activation leads to associated proliferation
via autocrine production of IL-2 (38). In this cellular scenario,
the physiological role of VDPC in the immune system remains
to be determined.
We have found that M-CSF-dependent proliferation led to an
increase in the K current conducted by Kv1.3. Links between
proliferation and VDPC expression are supported by the cell
growth arrest in the presence of K channel blockers (36, 46,
this study). M-CSF activates phosphorylation cascades that
involve Src homology 2 domains and induction of mitogen-
activated protein kinase (24). Kv1.3 shows tyrosine kinase
regulation and, in addition to its role as an ion channel, might
be involved in the activation of Src-like tyrosine kinases that
FIG. 7. TNF- up-regulates Kv1.3
and down-regulates Kir2.1 VDPC. A,
RT-PCR analysis of Kv1.3 and Kir2.1
mRNA expression at different times after
TNF- treatment. Results from RT-PCR
on 0.25 g of total RNA during 30 cycles
for Kv1.3 and Kir2.1 and 0.1 g of RNA
and 10 cycles for 18 S are shown. These
conditions were at the exponential phase
of the amplicon production as described
under “Experimental Procedures.” ,
Kv1.3; E, Kir2.1; f, 18 S. Significant dif-
ferences were found with Kv1.3 and
Kir2.1 (p  0.001, ANOVA). B, Kv1.3 and
Kir2.1 Western blot analysis. Cells were
incubated for 24 h with (TNF-) or with-
out (TNF-) the cytokine. Open bars,
Kv1.3; closed bars, Kir2.1; hatched bars,
-actin. *, p  0.05; **, p  0.01 versus
TNF- (Student’s t test). Representa-
tive filters are shown. Values are mean 
S.E. of four independent experiments.
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are important for cell growth (47, 48). However, our results go
further, because we demonstrate that the long term increase in
Kv1.3 activity is under de novo mRNA and protein synthesis,
similarly to what was observed with the inward K current and
Kir2.1. This is in contrast to what is described in phorbol
12-myristate 13-acetate-differentiated HL-60 cells or thiogly-
collate-elicited peritoneal macrophages (12). However, our re-
sults are in agreement with studies in which Ba2 inhibits
melanoma cell proliferation linked to a decrease in the mem-
brane depolarization (28).
The question arises as to why macrophages need both K
channels to proliferate. Whereas the Kv1.3 current could set
the membrane potential at 50 to 60 mV, Kir2.1 would shift
the potential to more negative values, close to the Nernst
potassium equilibrium. A similar mechanism operates during
myogenesis. Kir2.1 forces the potential to more negative values
than hERG channels, leading to cell fusion mediated by Ca2
(49). The degree of membrane hyperpolarization determines
the extent of Ca2 influx (49, 50). In macrophages, MgTx and
Ba2 inhibited proliferation and their combination was addi-
tive. In addition, MgTx and Ba2 partially block proliferation
in oligodendrocytes and melanoma cells (28, 36). These results
have physiological significance because an increase in intracel-
lular Ca2 activates calcineurin, the translocator of the tran-
scriptional factor NF-IL2A, the mitogen-activated protein II
kinase, and the DNA synthesis promoting factor (38, 51). Con-
sequently, by inducing Kv1.3 and Kir2.1, macrophages would
maintain sufficiently negative potential to open Ca2 channels
and thus initiate mitotic Ca2 signaling pathways.
LPS-induced activation blocks macrophage proliferation (25,
35) and regulates Kv1.3 and Kir2.1 under mRNA and protein
synthesis control. Previous studies show that K currents can
be differentially regulated. Whereas granulocyte macrophage-
CSF and LPS induce the outward current, without changes in
Kv1.3 mRNA, the inwardly rectifying current decreased in
microglia (19). In addition, transforming growth factor-, a
deactivating cytokine, induces Kv1.3 without any relevant ef-
fect on the inward current (52). In contrast, THP-1 phorbol
12-myristate 13-acetate-differentiated macrophages decreased
Kv1.3 concomitantly to an increase in Kir2.1 (15). Our results
suggest that LPS-induced activation regulates VDPC differen-
tially, probably fine tuning the membrane potential and dis-
criminating them from proliferative signals that require more
negative values.
By inducing Kv1.3 and repressing Kir2.1, macrophages re-
duce the Ca2 driving force, the intracellular K concentration
([K]i), and the membrane potential hyperpolarization. While
an increase in Ca2 initiates the mitogenic pathway, LPS-
induced activation does not mobilize Ca2 in macrophages (53).
LPS activates macrophages and generates apoptosis in several
cell types (25). Kv1.3 functions relatively early in the pro-
apoptotic cascade in T-cells and neurons (54, 55). In addition, a
decrease in [K]i is involved in the formation of the apoptosome
(56). This is consistent with the Kv1.3 and Kir2.1 regulation
that we observed. Thus, a loss of cytosolic K is related to
thymocyte apoptosis and partially protected by blocking K
channels (57). On the other hand, VDPC blockers and depolar-
izing agents cause p27kip1 and p21cip1(waf-1) accumulation and
G1 arrest in oligodendrocyte progenitors (58). Furthermore, a
p21cip1(waf-1) increase is associated with the cell growth inhibi-
tion in interferon--activated macrophages (59). However, al-
though p21cip1(waf-1) could play a role in the inhibition of macro-
FIG. 8. Evidence for TNF--independent mechanisms mediating the VDPC regulatory responses to LPS in macrophages. Cells
cultured in the absence of M-CSF for 18 h were incubated for a further 24 h in the presence of the growth factor supplemented with LPS or TNF-.
Samples from wild type (/) or TNF- receptor I/II double knockout (/) mice were collected at the indicated times. A, RT-PCR analysis of Kv1.3
and Kir2.1 mRNA expression after LPS treatment. RT-PCR results were at the exponential phase of the amplicon production as described in the
legend to Fig. 5. Significant differences were found in Kv1.3 and Kir2.1 (p  0.001, ANOVA). , E: Kv1.3; f, : Kir2.1; Œ, ‚: 18 S. Closed symbols,
/; open symbols, /. B, Kv1.3 and Kir2.1 Western blot analysis. Cells were incubated for 24 h with (LPS) or without (LPS) the endotoxin.
Open bars, Kv1.3; closed bars, Kir2.1; hatched bars, -actin. *, p  0.05; **, p  0.01 versus LPS (Student’s t test). C, RT-PCR analysis of Kv1.3
and Kir2.1 mRNA expression after TNF- treatment. RT-PCR results were at the exponential phase of the amplicon production as described in
the legend to Fig. 7. Symbols are described in A. Kv1.3 and Kir2.1 significant differences were found only in / macrophages (p  0.001, ANOVA).
D, Kv1.3 and Kir2.1 Western blot analysis. Cells were incubated for 24 h with (TNF-) or without (TNF-) the cytokine. Symbols are described
in B. *, p  0.05; **, p  0.01 versus TNF- (Student’s t test). Representative filters are shown. Values are mean  S.E. of four independent
experiments.
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FIG. 9. VDPC regulation is dependent on de novo mRNA and protein synthesis and Kv1.3 is involved in BMDM activation and
proliferation. Macrophages were cultured in the absence of M-CSF for 18 h, then G0-arrested cells were further incubated for 24 h in the absence
(basal) or presence of M-CSF with or without LPS or TNF-. A, regulation of K currents is dependent on de novo synthesis of mRNA and protein.
K current induction was inhibited by the addition of either 5 g/ml actinomycin D (closed bars) or 5 g/ml cycloheximide (hatched bars) during
the treatment. Cells were held at 60 mV and currents were elicited by depolarizing pulses of 50 mV (outward current) and hyperpolarizing
pulses of 150 mV (inward currents). Values are the mean  S.E. of at least six independent cells. B and C, inhibition of the outward K current
by MgTx and ShK-Dap22, respectively. E, basal; , M-CSF; , LPS; f, TNF-. D, Kv1.5 mRNA expression analyzed by RT-PCR in BMDM. See
“Experimental Procedures” for details. E, MgTx inhibits M-CSF-dependent proliferation in macrophages. Macrophages were cultured in the
absence of M-CSF for 18 h. Cells were further incubated during 24 h with or without the growth factor (1200 units/ml) in the presence of increasing
concentrations of MgTx. Sample collection was performed as described under “Experimental Procedures.” Values are the mean  S.E. of four
different assays each done in triplicate. F, Kv1.3 is involved in the LPS- and TNF--induced activation. Proliferating macrophages were cultured
during 24 h in the absence () or presence () of LPS and TNF- with or without 10 nM MgTx. iNOS protein expression was determined as
described under “Experimental Procedures.” A representative Western blot of three independent experiments is shown.
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phage proliferation by K channels, other mechanisms may be
involved. Thus, cyclin D, essential for G1/S progression, is
regulated by extracellular signals (59). In this context, the
induction of Kv1.3 associated with a Kir2.1 decrease would
increase the extracellular K concentration. Similar depolar-
ization activates T-cell 1 integrin moieties initiating T-cell
immune reactions (60).
Role of TNF-—Most of the effects of LPS during endotoxic
shock are associated with the secretion of TNF- by tissue
macrophages (25). TNF- affects the growth and function of
many cell types, and is a major mediator of inflammatory
immune responses upon the activation of p55 type I and p75
type II receptors (61). Several lines of evidence implicate
TNF- in LPS-induced regulation of VDPC. First, TNF-
blocks proliferation and is involved in several LPS-induced
mechanisms such as apoptosis and nucleoside transport (25,
35). Second, the time course of VDPC regulation probably co-
incides with the early induction of TNF- mRNA expression
(25). Finally, the production of TNF- requires K channel
activity (62).
TNF- mimicked the LPS differential regulation of VDPC.
However, this affirmation is only partially correct. Whereas the
effects on Kir2.1 were similar, Kv1.3 showed some differences.
Results on current densities and knockout mice suggest that
LPS regulation involves TNF-dependent and -independent
mechanisms. Indeed, TNF- inhibits cell proliferation but the
further addition of either MgTx or Ba2 was additive.
In the bone marrow, TNF- induces DNA fragmentation and
cell death by apoptosis (25, 35). The activation of caspase 8
initiates the cascade of caspases that leads to apoptosis, appar-
ently without any second messengers (25). However, alter-
ations in ion composition regulate the activity of effector
caspases and nucleases, thereby regulating pro-apoptotic sig-
nals (63). As indicated above, differential regulation of VDPC
could modify this intracellular ion composition. Indeed, a 25
mV change modifies IL-2 production, thus reducing the activa-
tion and the antibody production by lymphocytes (50). Thus,
differences between the LPS and TNF- regulation of Kv1.3
and Kir2.1 currents could separate the two situations trigger-
ing the required and specific immune response.
Evidence for Post-translational Control of Kv1.3 during Ac-
tivation—Ion channels are under extensive regulation, and
changes among expression levels have been reported. However,
in long term studies, VDPC mRNA mostly governs protein and
activity (13, 34, 36). Although our results indicate that VDPC
are mainly regulated at the transcriptional level, which is
translated to protein abundance, which in turn would be re-
sponsible for changes in current amplitudes, other alternative
mechanisms, such as changes in mRNA stability, should not be
discarded.
While M-CSF-dependent proliferation did not modify the
steady-state activation curves for Kv1.3 and Kir2.1, LPS and
TNF- reduced the k value of Kv1.3. Previous studies suggest
that K channels are involved in T-cell activation and provide
evidence of post-translational processes. Thus, Kv1.3 could be
phosphorylated by several kinases (38, 47). In addition, confor-
mational changes of the K channel structure are possible by
high K concentrations outside the T-cell (60). Finally, the
heteromeric structure of the Kv1.3 associated with Kv1.5 and
Kv regulatory subunits could define a wide diversity of phys-
iological activities and immunological functions (64). Indeed,
LPS induces Kv1.1 and Kv2.1 in T-cells and splenocytes (65).
Changes in Kv subunits during macrophage activation could
indeed modify the kinetics of the de novo synthesized K chan-
nels as observed during myogenesis (34). Work is in progress
in our laboratory to elucidate the role of these modulatory
subunits and some preliminary results have been recently
described (66).
In summary, we provide strong evidence that proliferation
and activation require specific VDPC modulation that would
determine appropriate signals for each process. Furthermore,
VDPC regulation by LPS implies redundant pathways in which
the endotoxin participates by TNF--dependent and -independ-
ent mechanisms that would trigger differential responses. Our
results have physiological significance because the channels
might control the cell physiology and their activity may also be
modulated by changes in the K gradient. Thus, a loss of [K]i
occurs in immunologically relevant situations such as cellular
injury, stress, and inflammation (60). In this context, VDPC
could buffer K and modulate cellular responses. Finally, our
results indicate that K channels should be considered as
pharmacological targets in anti-inflammatory and immuno-
modulation therapies.
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F. J., Argilés, J. M., and Felipe, A. (2003) FEBS Lett. 536, 45–50
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